Neutrogena Beach Defense Sunscreen Spray Recall Due to cGMP Deviations
Johnson & Johnson Consumer, Inc. is recalling Neutrogena Beach Defense water+sun protection sunscreen spray (SPF 70) nationwide due to cGMP deviations. This is a voluntary recall initiated by the manufacturer.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall, voluntary and firm-initiated, with no reported illnesses or injuries. The hazard is manufacturing deviation without confirmed product contamination or safety failure. Per the rubric, manufacturing violations without reported harm and voluntary recalls are typically scored as 2 (Moderate).
Plain-English summary
Johnson & Johnson Consumer, Inc. is recalling Neutrogena Beach Defense water+sun protection sunscreen spray (BROAD SPECTRUM SPF 70) containing Avobenzone (3%), Homosalate (15%), Octisalate (5%), and Octocrylene (10%). The recall involves two package sizes: 6.5 oz (184 g) cans (UPC 0 86800 87274 0) and 8.5 oz (240 g) cans (UPC 0 86800 10048 5).
The recall was initiated due to cGMP (Current Good Manufacturing Practice) deviations. This is a voluntary recall initiated by the firm. The affected product was distributed nationwide in the United States. All lots within expiry are included in this recall.
Consumers in possession of the recalled sunscreen should discontinue use. For additional information or questions, consumers may contact the recalling firm through official FDA channels at https://www.fda.gov/drugs/drug-safety-and-availability/drug-recalls.
The recalled product
- Product
- Neutrogena Beach Defense water+sun protection sunscreen spray BROAD SPECTRUM SPF 70, Avobenzone (3%), Homosalate (15%), Octisalate (5%), Octocrylene (10%), a) NET WT. 6.5 OZ. (184 g) (UPC 0 86800 87274 0) and b) NET WT. 8.5 OZ. (240 g) (UPC 0 86800 10048 5) aerosol can, Distribut
- Manufacturer
- Johnson & Johnson Consumer, Inc.
- Hazard
- cGMP-deviation
- manufacturing-defect
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots within expiry
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-06-17
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27